Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours Β· Estimated delivery Sep 25 - Sep 30
Both medication options have their own FDA approvals, meaning Mounjaro should not be used for weight loss, and Zepbound should not be prescribed for diabetes
5.2 Acute Pancreatitis Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists [see Adverse Reactions (6)]
Potential Benefits * Weight Management Support May assist with weight reduction when used with lifestyle modifications * Appetite Regulation May help reduce hunger and increase feelings of fullness * Personalized Approach Custom dosing tailored to your individual needs and response How to Use Administered as a once-weekly subcutaneous injection
For individuals seeking support with weight management or metabolic health, NICE-appraised options are available through appropriate NHS or private channels
US$ 24.72
US$ 27.53
US$ 21.42
US$ 24.01
US$ 27.66
US$ 29.62
US$ 27.69
